Avotres Inc.
PrivateLast Round
Series A
Feb 24, 2021
Total Funding Raised
$4M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Avotres Inc. operates in Healthcare & Life Sciences and is based in New Jersey. Its latest recorded funding round was a Series A round in February 2021.
Avotres Inc. is a biotechnology company that develops novel immune-regulating therapies for autoimmune diseases, cancers, and transplantation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avotres Inc. Comparables
Compare Avotres Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mozart Therapeutics | 88% | |
| GentiBio | 84% | |
| Tr1X | 84% |
For institutional investors. Book with your work email.
Avotres Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Avotres Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Photon Fund | Series A |
| Foothill Ventures | Series A |
| Proxima Ventures Ltd. | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 109% MoM, reaching 4.1K.
- Jul 25, 2026
Monthly visitors increased 159% MoM, reaching 1.9K.
For institutional investors. Book with your work email.
Avotres Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Avotres Inc.'s valuation, stock price, and market status.
Is Avotres Inc. a public or private company?
Avotres Inc. is a private company.
What is the current stock price of Avotres Inc.?
Avotres Inc. is a private company, so its shares have no public market price. Caplight tracks Avotres Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Avotres Inc. worth (valuation)?
Valuation information for Avotres Inc. is not publicly available.
Can I buy Avotres Inc. stock?
Avotres Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Avotres Inc.'s last funding round?
Avotres Inc.'s most recent funding round was Series A on February 24, 2021.
Who are the main investors in Avotres Inc.?
Key investors in Avotres Inc. include Photon Fund, Foothill Ventures, Proxima Ventures Ltd..
Will Avotres Inc. IPO soon?
No public IPO plans have been announced for Avotres Inc..
How can I track Avotres Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Avotres Inc.'s shares on secondary markets.